Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 6/1/2023 | $99.00 | Neutral | UBS |
SC 13G/A - EXPONENT INC (0000851520) (Subject)
SC 13G/A - EXPONENT INC (0000851520) (Subject)
SC 13G/A - EXPONENT INC (0000851520) (Subject)
MENLO PARK, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Exponent, Inc. (NASDAQ:EXPO) today reported financial results for the fourth quarter and fiscal year 2024 ended January 3, 2025. "Our fourth quarter results exceeded expectations, capping off a solid year that demonstrated the resilience of the business. With a laser focus on aligning resources with demand, we grew net revenues in the mid-single digits for the year and at the same time delivered significantly improved utilization and EBITDA1 margin. We achieved growth across both proactive and reactive services in the year, with consumer electronics and utilities fueling proactive growth and utilities and medical devices supporti
MENLO PARK, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Exponent, Inc. (NASDAQ:EXPO) today announced that its Board of Directors has raised its quarterly cash dividend from $0.28 to $0.30 per share of common stock. The quarterly cash dividend of $0.30 per share of common stock is to be paid on March 21, 2025 to all common stockholders of record as of March 7, 2025. Exponent has paid, and expects to continue to pay, quarterly dividends each year in March, June, September, and December. Future declarations of quarterly dividends and the establishment of future record and payment dates are subject to the final determination of Exponent's Board of Directors. "This is the 12th consecutive year
MENLO PARK, Calif., Jan. 16, 2025 (GLOBE NEWSWIRE) -- Exponent, Inc. (NASDAQ:EXPO), today announced that it will report Fourth Quarter and fiscal year 2024 financial results for the period ended January 3, 2025 following the close of the market on Thursday, February 6, 2025. On that day, Dr. Catherine Corrigan, Chief Executive Officer and President, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) to discuss the Company's business and financial results. Event:Exponent, Inc. Fourth Quarter and Fiscal Year 2024 Financial Results Conference CallDate:Thursday, February 6, 2025Time:4:30 p.m. East
5 - EXPONENT INC (0000851520) (Issuer)
5 - EXPONENT INC (0000851520) (Issuer)
5 - EXPONENT INC (0000851520) (Issuer)
8-K - EXPONENT INC (0000851520) (Filer)
8-K - EXPONENT INC (0000851520) (Filer)
10-Q - EXPONENT INC (0000851520) (Filer)
MENLO PARK, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Exponent, Inc. (NASDAQ:EXPO) today reported financial results for the fourth quarter and fiscal year 2024 ended January 3, 2025. "Our fourth quarter results exceeded expectations, capping off a solid year that demonstrated the resilience of the business. With a laser focus on aligning resources with demand, we grew net revenues in the mid-single digits for the year and at the same time delivered significantly improved utilization and EBITDA1 margin. We achieved growth across both proactive and reactive services in the year, with consumer electronics and utilities fueling proactive growth and utilities and medical devices supporti
MENLO PARK, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Exponent, Inc. (NASDAQ:EXPO) today announced that its Board of Directors has raised its quarterly cash dividend from $0.28 to $0.30 per share of common stock. The quarterly cash dividend of $0.30 per share of common stock is to be paid on March 21, 2025 to all common stockholders of record as of March 7, 2025. Exponent has paid, and expects to continue to pay, quarterly dividends each year in March, June, September, and December. Future declarations of quarterly dividends and the establishment of future record and payment dates are subject to the final determination of Exponent's Board of Directors. "This is the 12th consecutive year
MENLO PARK, Calif., Jan. 16, 2025 (GLOBE NEWSWIRE) -- Exponent, Inc. (NASDAQ:EXPO), today announced that it will report Fourth Quarter and fiscal year 2024 financial results for the period ended January 3, 2025 following the close of the market on Thursday, February 6, 2025. On that day, Dr. Catherine Corrigan, Chief Executive Officer and President, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) to discuss the Company's business and financial results. Event:Exponent, Inc. Fourth Quarter and Fiscal Year 2024 Financial Results Conference CallDate:Thursday, February 6, 2025Time:4:30 p.m. East
UBS initiated coverage of Exponent with a rating of Neutral and set a new price target of $99.00